HUM vs SLS · P/E 39, rev $117.76B vs $1.62B cap
Humana Inc (HUM) versus Sellas Life Sciences Group Inc (SLS) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$9.6M. SLS currently screens at market cap $1.62B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. SLS currently screens at market cap $1.62B.
Not investment advice. Open the HUM and SLS stock pages for the full models.
Not investment advice.